Amarin signs agreement with Neopharm to market VAZKEPA in Israel
Amarin has entered into an exclusive marketing and commercialisation agreement with Neopharm for VAZKEPA in the State of Israel, Gaza, West Bank and the territories of the Palestinian Authority.